Fjarde AP Fonden Fourth Swedish National Pension Fund Purchases 37,200 Shares of CVS Health Corporation $CVS

Fjarde AP Fonden Fourth Swedish National Pension Fund increased its holdings in CVS Health Corporation (NYSE:CVS) by 21.5% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 210,019 shares of the pharmacy operator’s stock after acquiring an additional 37,200 shares during the quarter. Fjarde AP Fonden Fourth Swedish National Pension Fund’s holdings in CVS Health were worth $14,487,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors and hedge funds have also recently modified their holdings of the company. Hazlett Burt & Watson Inc. increased its position in shares of CVS Health by 10.9% during the second quarter. Hazlett Burt & Watson Inc. now owns 1,682 shares of the pharmacy operator’s stock valued at $117,000 after acquiring an additional 165 shares in the last quarter. Williams Financial LLC grew its position in CVS Health by 2.5% in the 2nd quarter. Williams Financial LLC now owns 6,923 shares of the pharmacy operator’s stock worth $478,000 after purchasing an additional 167 shares during the period. Hemington Wealth Management grew its holdings in shares of CVS Health by 33.7% in the first quarter. Hemington Wealth Management now owns 682 shares of the pharmacy operator’s stock worth $46,000 after acquiring an additional 172 shares during the period. Sumitomo Life Insurance Co. grew its holdings in shares of CVS Health by 1.0% in the first quarter. Sumitomo Life Insurance Co. now owns 17,114 shares of the pharmacy operator’s stock worth $1,159,000 after acquiring an additional 174 shares during the period. Finally, Koshinski Asset Management Inc. grew its holdings in shares of CVS Health by 3.7% in the first quarter. Koshinski Asset Management Inc. now owns 4,930 shares of the pharmacy operator’s stock worth $334,000 after acquiring an additional 178 shares during the period. 80.66% of the stock is currently owned by institutional investors.

CVS Health Trading Down 0.2%

Shares of CVS Health stock opened at $82.30 on Wednesday. The company has a market capitalization of $104.39 billion, a P/E ratio of 22.99, a P/E/G ratio of 0.91 and a beta of 0.60. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.62 and a current ratio of 0.80. The company has a fifty day moving average of $76.05 and a 200 day moving average of $68.84. CVS Health Corporation has a fifty-two week low of $43.56 and a fifty-two week high of $83.74.

CVS Health (NYSE:CVS) last issued its earnings results on Thursday, July 31st. The pharmacy operator reported $1.81 earnings per share for the quarter, topping the consensus estimate of $1.46 by $0.35. The company had revenue of $98.92 billion during the quarter, compared to the consensus estimate of $94.87 billion. CVS Health had a net margin of 1.17% and a return on equity of 10.51%. CVS Health’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $1.83 EPS. CVS Health has set its FY 2025 guidance at 6.300-6.400 EPS. On average, sell-side analysts anticipate that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Monday, November 3rd. Shareholders of record on Thursday, October 23rd will be paid a $0.665 dividend. This represents a $2.66 annualized dividend and a yield of 3.2%. The ex-dividend date is Thursday, October 23rd. CVS Health’s dividend payout ratio is presently 74.30%.

Insiders Place Their Bets

In related news, Director Anne A. Finucane sold 7,500 shares of the company’s stock in a transaction on Wednesday, August 20th. The shares were sold at an average price of $71.02, for a total transaction of $532,650.00. Following the completion of the transaction, the director owned 22,156 shares in the company, valued at approximately $1,573,519.12. This represents a 25.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 1.22% of the stock is owned by insiders.

Analysts Set New Price Targets

A number of equities research analysts have issued reports on CVS shares. Sanford C. Bernstein boosted their price target on CVS Health from $72.00 to $77.00 and gave the company a “market perform” rating in a research note on Friday, September 5th. Wells Fargo & Company boosted their target price on shares of CVS Health from $84.00 to $103.00 and gave the company an “overweight” rating in a research report on Tuesday, October 7th. Barclays boosted their target price on shares of CVS Health from $80.00 to $87.00 and gave the company an “overweight” rating in a research report on Thursday, September 4th. The Goldman Sachs Group started coverage on shares of CVS Health in a research report on Tuesday, October 14th. They set a “buy” rating and a $91.00 target price for the company. Finally, Baird R W raised shares of CVS Health from a “hold” rating to a “strong-buy” rating in a research report on Thursday, August 14th. Two investment analysts have rated the stock with a Strong Buy rating, twenty have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, CVS Health currently has a consensus rating of “Moderate Buy” and a consensus target price of $83.38.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.